PMV Pharmaceuticals, Inc. SEC filings PMVP
PMV Pharmaceuticals, Inc. has 390 filings in SEC EDGAR's recent list, going back to Mar 2, 2017. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 5, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Nov 27, 2024 | — |
| CORRESP | Letter to the SEC | Nov 25, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 25, 2024 | — |
| SC TO-I/A | Filing | Aug 14, 2024 | — |
| SC TO-I | Filing | Jul 16, 2024 | — |
| EFFECT | Filing | Apr 28, 2023 | — |
| POSASR | Filing | Mar 1, 2023 | — |
| EFFECT | Filing | Sep 24, 2020 | — |
| CERT | Filing | Sep 24, 2020 | — |
| CORRESP | Letter to the SEC | Sep 22, 2020 | — |
| CORRESP | Letter to the SEC | Sep 22, 2020 | — |
| 8-A12B | Filing | Sep 21, 2020 | — |
| CORRESP | Letter to the SEC | Sep 21, 2020 | — |
| UPLOAD | Letter from the SEC | Sep 17, 2020 | — |
| CORRESP | Letter to the SEC | Sep 11, 2020 | — |
| CORRESP | Letter to the SEC | Sep 4, 2020 | — |
| UPLOAD | Letter from the SEC | Aug 18, 2020 | — |
| DRS/A | Filing | Aug 3, 2020 | — |
| DRSLTR | Filing | Jul 31, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 23, 2020 | — |
| DRS | Filing | Jun 26, 2020 | — |
| D | Filing | Mar 2, 2017 | — |
Showing 22 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PMVP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Princeton, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1699382
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.